Harvard University researchers should be able to get drugs to market far quicker after a hedge fund ploughed $100 million into a new R&D partnership.
The hedge fund Deerfield Management is investing $100 million in a partnership with Harvard University.
Harvard University researchers should be able to get drugs to market far quicker after a hedge fund plowed $100 million into a new research and partnership.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Giant hedge fund Citadel is closing its Aptigon stock-picking unitEric Felder, who led Aptigon and the firm's global credit team, left the firm Thursday, sources tell Business Insider, while a majority of the teams in the stock-picking unit will be reassigned to one of Citadel's three remaining stock-picking teams.
Read more »
'Pain + Reflection=Progress': Here are 13 brilliant quotes from hedge-fund legend Ray Dalio'Pain + Reflection = Progress': Here are 13 brilliant quotes from hedge-fund legend Ray Dalio
Read more »
Tesla won't 'ever report another profitable quarter,' former hedge-fund manager Whitney Tilson saysThe former hedge-fund manager Whitney Tilson doubled down on his Tesla short thesis on Friday, predicting the company won't ever be profitable again.
Read more »
Here are the world's 17 richest hedge-fund billionairesHere are the richest hedge-fund managers in the world, based on Forbes' 2019 billionaires report.
Read more »
Trump wants the e-cigarette industry to pay $100 million a year in user feesThe proposal, if approved by Congress, would provide funds to increase Food and Drug Administration oversight of the vaping industry.
Read more »
Bank of America, the Tory Burch Foundation to offer $100 million in loans to women entrepreneursBank of America, the Tory Burch Foundation to offer $100 million in loans to women entrepreneurs via CNBCMakeIt
Read more »
Fast-Growing Lab Properties Attracting New Wave of CashThe prospect of big rent increases is drawing more large property investors to the risky but fast-growing niche of biotechnology and other life-science buildings.
Read more »
Hedge Fund Tosses Family That Controls Maker of OxyContinThe billionaire family that controls OxyContin maker Purdue Pharma, already facing mounting legal and financial pressure, has been tossed out of a large hedge fund for its alleged role in fueling the opioid crisis.
Read more »
The Hedge Fund Manager Who Bucked The Trend And Became A BillionaireJeffrey Talpins, founder of Element Capital Management, has built a $17 billion firm and is now a billionaire.
Read more »
A new hedge fund with one of the biggest debuts of 2018 is shorting Adidas in a trade worth $243 millionD1 Capital Partners is short Adidas, placing a 'rare' bet worth about 216 million euros ($243 million) that its shares will go down.
Read more »